Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

France Dysmenorrhea Treatment Market

ID: MRFR/HC/52778-HCR
200 Pages
Rahul Gotadki
Last Updated: March 28, 2026

France Dysmenorrhea Treatment Market Research Report: Size, Share, Trend Analysis By Product Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), By Types of Treatment (Pain Relievers, Hormonal Therapy, Surgery), andBy End-User (Hospitals & Clinics, Research Centers) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

France Dysmenorrhea Treatment Market Infographic
Purchase Options
  1. 1 EXECUTIVE SUMMARY
    1. Market Overview
    2. 1.2 Key Findings
    3. 1.3 Market Segmentation
    4. Competitive Landscape
    5. 1.5 Challenges and Opportunities
    6. 1.6 Future
    7. Outlook
  2. 2 MARKET INTRODUCTION
    1. 2.1 Definition
    2. 2.2 Scope of the study
      1. 2.2.1 Research Objective
      2. 2.2.2 Assumption
      3. 2.2.3 Limitations
  3. 3 RESEARCH METHODOLOGY
    1. 3.1 Overview
    2. Data Mining
    3. 3.3 Secondary Research
    4. 3.4 Primary Research
      1. 3.4.2 Breakdown of Primary
    5. Primary Interviews and Information Gathering Process
    6. Respondents
    7. 3.5 Forecasting Model
    8. 3.6 Market Size Estimation
      1. 3.6.2 Top-Down Approach
    9. Bottom-Up Approach
    10. 3.7 Data Triangulation
    11. 3.8 Validation
  4. 4 MARKET DYNAMICS
    1. 4.1 Overview
    2. 4.2 Drivers
    3. 4.3 Restraints
    4. 4.4 Opportunities
  5. 5 MARKET
  6. FACTOR ANALYSIS
    1. 5.1 Value chain Analysis
    2. 5.2 Porter's Five Forces
      1. 5.2.1 Bargaining Power of Suppliers
      2. 5.2.2 Bargaining Power
      3. 5.2.3 Threat of New Entrants
      4. 5.2.4 Threat of Substitutes
      5. 5.2.5 Intensity of Rivalry
    3. Analysis
    4. of Buyers
    5. 5.3 COVID-19 Impact Analysis
      1. 5.3.2 Regional Impact
      2. 5.3.3 Opportunity and
    6. Market Impact Analysis
    7. Threat Analysis
  7. 6 France Dysmenorrhea Treatment Market,
    1. BY PRODUCT TYPE (USD MILLION)
    2. 6.1 Primary Dysmenorrhea
    3. 6.2 Secondary
    4. Dysmenorrhea
  8. 7 France Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT
    1. (USD MILLION)
    2. 7.1 Pain Relievers
    3. 7.2 Hormonal Therapy
    4. 7.3 Surgery
  9. 8 France Dysmenorrhea Treatment Market, BY END-USER (USD MILLION)
    1. Hospitals & Clinics
    2. 8.2 Research Centers
  10. 9 COMPETITIVE
    1. LANDSCAPE
    2. 9.1 Overview
    3. 9.2 Competitive Analysis
    4. 9.3 Market
    5. share Analysis
    6. 9.4 Major Growth Strategy in the Dysmenorrhea Treatment Market
    7. 9.5 Competitive Benchmarking
    8. 9.6 Leading Players in Terms of Number
    9. of Developments in the Dysmenorrhea Treatment Market
    10. 9.7 Key developments
      1. 9.7.1 New Product Launch/Service Deployment
      2. 9.7.3 Joint Ventures
    11. and growth strategies
    12. Merger & Acquisitions
    13. 9.8 Major Players Financial
      1. 9.8.1 Sales and Operating Income
      2. 9.8.2 Major Players R&D
    14. Matrix
    15. Expenditure. 2023
  11. 10 COMPANY PROFILES
    1. 10.1 Novartis
      1. 10.1.2 Products Offered
      2. 10.1.3 Key Developments
      3. 10.1.4 SWOT Analysis
      4. 10.1.5 Key Strategies
    2. Financial Overview
    3. 10.2 Roche
      1. 10.2.2 Products Offered
      2. 10.2.3 Key Developments
      3. 10.2.4 SWOT Analysis
      4. 10.2.5 Key Strategies
    4. Financial Overview
    5. 10.3 Sanofi
      1. 10.3.1 Financial Overview
      2. 10.3.2 Products Offered
      3. 10.3.3 Key Developments
      4. 10.3.4 SWOT Analysis
      5. 10.3.5 Key Strategies
    6. 10.4 HRA Pharma
      1. 10.4.1 Financial Overview
      2. 10.4.2 Products Offered
      3. 10.4.3 Key
      4. 10.4.4 SWOT Analysis
      5. 10.4.5 Key Strategies
      6. 10.5.1 Financial Overview
      7. 10.5.2 Products Offered
      8. 10.5.3 Key Developments
      9. 10.5.4 SWOT Analysis
      10. 10.5.5 Key Strategies
    7. Developments
    8. Johnson & Johnson
    9. 10.6 Bayer
      1. 10.6.1 Financial Overview
      2. 10.6.2 Products Offered
      3. 10.6.3 Key Developments
      4. 10.6.4 SWOT Analysis
      5. 10.6.5 Key Strategies
    10. 10.7 Endo International
      1. 10.7.1 Financial Overview
      2. 10.7.2 Products
      3. 10.7.3 Key Developments
      4. 10.7.4 SWOT Analysis
    11. Offered
    12. Key Strategies
    13. 10.8 Merck & Co
      1. 10.8.1 Financial Overview
      2. 10.8.3 Key Developments
      3. 10.8.4 SWOT Analysis
      4. 10.8.5 Key Strategies
    14. Products Offered
    15. 10.9 BristolMyers Squibb
      1. 10.9.1 Financial
      2. 10.9.2 Products Offered
      3. 10.9.3 Key Developments
      4. 10.9.5 Key Strategies
    16. Overview
    17. SWOT Analysis
    18. 10.10 AstraZeneca
      1. 10.10.2 Products Offered
      2. 10.10.3 Key Developments
      3. 10.10.4 SWOT Analysis
      4. 10.10.5 Key Strategies
    19. Financial Overview
    20. 10.11 Mylan
      1. 10.11.1 Financial Overview
      2. 10.11.2 Products Offered
      3. 10.11.3 Key
      4. 10.11.4 SWOT Analysis
      5. 10.11.5 Key Strategies
      6. 10.12.1 Financial Overview
      7. 10.12.2 Products Offered
      8. 10.12.4 SWOT Analysis
      9. 10.12.5 Key Strategies
    21. Developments
    22. Pfizer
    23. Key Developments
    24. 10.13 AbbVie
      1. 10.13.1 Financial Overview
      2. 10.13.2 Products Offered
      3. 10.13.3 Key Developments
      4. 10.13.4 SWOT Analysis
      5. 10.13.5 Key
    25. Strategies
    26. 10.14 GlaxoSmithKline
      1. 10.14.1 Financial Overview
      2. 10.14.3 Key Developments
      3. 10.14.4 SWOT Analysis
      4. 10.14.5 Key Strategies
    27. Products Offered
    28. 10.15 Teva Pharmaceuticals
      1. 10.15.1 Financial
      2. 10.15.2 Products Offered
      3. 10.15.3 Key Developments
      4. 10.15.5 Key Strategies
    29. Overview
    30. SWOT Analysis
  12. 11 APPENDIX
    1. 11.1 References
    2. 11.2 Related Reports
  13. LIST OF TABLES
  14. TABLE 1 LIST OF ASSUMPTIONS
  15. TABLE 2 FRANCE DYSMENORRHEA TREATMENT MARKET SIZE ESTIMATES & France Dysmenorrhea Treatment Market,
    1. BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
  16. TABLE 3 FRANCE DYSMENORRHEA TREATMENT
  17. MARKET SIZE ESTIMATES & France Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2019-2035 (USD BILLIONS)
  18. TABLE 4 FRANCE DYSMENORRHEA TREATMENT MARKET SIZE ESTIMATES & France Dysmenorrhea Treatment Market,
    1. BY END-USER, 2019-2035 (USD BILLIONS)
  19. TABLE 5 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  20. TABLE 6 ACQUISITION/PARTNERSHIP
  21. LIST OF FIGURES
    1. FIGURE
  22. 1 MARKET SYNOPSIS
  23. FIGURE 2 FRANCE DYSMENORRHEA TREATMENT MARKET ANALYSIS
    1. BY PRODUCT TYPE
  24. FIGURE 3 FRANCE DYSMENORRHEA TREATMENT MARKET ANALYSIS BY
    1. TYPE OF TREATMENT
  25. FIGURE 4 FRANCE DYSMENORRHEA TREATMENT MARKET ANALYSIS
    1. BY END-USER
  26. FIGURE 5 KEY BUYING CRITERIA OF DYSMENORRHEA TREATMENT MARKET
  27. FIGURE 6 RESEARCH PROCESS OF MRFR
  28. FIGURE 7 DRO ANALYSIS OF DYSMENORRHEA
  29. TREATMENT MARKET
  30. FIGURE 8 DRIVERS IMPACT ANALYSIS: DYSMENORRHEA TREATMENT
    1. MARKET
  31. FIGURE 9 RESTRAINTS IMPACT ANALYSIS: DYSMENORRHEA TREATMENT MARKET
  32. FIGURE 10 SUPPLY / VALUE CHAIN: DYSMENORRHEA TREATMENT MARKET
    1. FIGURE
  33. 11 France Dysmenorrhea Treatment Market, BY PRODUCT TYPE, 2025 (% SHARE)
    1. FIGURE
  34. 12 France Dysmenorrhea Treatment Market, BY PRODUCT TYPE, 2019 TO 2035 (USD Billions)
  35. FIGURE 13 France Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2025 (% SHARE)
  36. FIGURE 14 France Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2019 TO 2035
    1. (USD Billions)
  37. FIGURE 15 France Dysmenorrhea Treatment Market, BY END-USER, 2025
    1. (% SHARE)
  38. FIGURE 16 France Dysmenorrhea Treatment Market, BY END-USER, 2019 TO 2035
    1. (USD Billions)
  39. FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS

France Dysmenorrhea Treatment Market Segmentation

 

 

 

  • France Dysmenorrhea Treatment Market By Product Type (USD Million, 2019-2035)

    • Primary Dysmenorrhea
    • Secondary Dysmenorrhea

 

  • France Dysmenorrhea Treatment Market By Type of Treatment (USD Million, 2019-2035)

    • Pain Relievers
    • Hormonal Therapy
    • Surgery

 

  • France Dysmenorrhea Treatment Market By End-User (USD Million, 2019-2035)

    • Hospitals & Clinics
    • Research Centers

 

 

 

 

 

 

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions